10245 related articles for article (PubMed ID: 10333225)
1. Malignant melanoma with prominent pigment synthesis: "animal type" melanoma--a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis.
Crowson AN; Magro CM; Mihm MC
Hum Pathol; 1999 May; 30(5):543-50. PubMed ID: 10333225
[TBL] [Abstract][Full Text] [Related]
2. Melanoma with prominent pigment synthesis (animal-type melanoma): a case report with ultrastructural studies.
Kazakov DV; Rütten A; Kempf W; Michal M
Am J Dermatopathol; 2004 Aug; 26(4):290-7. PubMed ID: 15249859
[TBL] [Abstract][Full Text] [Related]
3. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
4. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma.
Antony FC; Sanclemente G; Shaikh H; Trelles AS; Calonje E
Histopathology; 2006 May; 48(6):754-62. PubMed ID: 16681693
[TBL] [Abstract][Full Text] [Related]
5. Meyerson Phenomenon as a Component of Melanoma in situ.
Sezer E; Özturk Durmaz E; Çetin E; Şahin S
Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
[TBL] [Abstract][Full Text] [Related]
6. Animal type melanoma: a report of a case with balloon-cell change and sentinel lymph node metastasis.
Requena L; de la Cruz A; Moreno C; Sangüeza O; Requena C
Am J Dermatopathol; 2001 Aug; 23(4):341-6. PubMed ID: 11481528
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
8. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
9. Idiosyncrasies of scalp melanoma.
Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
Eyden B; Pandit D; Banerjee SS
Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
[TBL] [Abstract][Full Text] [Related]
11. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
Mérot Y; Mihm MC
Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration biopsy of metastatic melanoma. A morphologic analysis of 174 cases.
Perry MD; Gore M; Seigler HF; Johnston WW
Acta Cytol; 1986; 30(4):385-96. PubMed ID: 3461649
[TBL] [Abstract][Full Text] [Related]
13. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
15. Animal-type melanoma - tumor cell invasion of dermal lymphatics and molecular identification of lymph node metastasis.
Posch C; Vesely M; Monshi B; Feichtinger H; Cziegler K; Rappersberger K
J Dtsch Dermatol Ges; 2012 Jan; 10(1):38-41. PubMed ID: 21539708
[TBL] [Abstract][Full Text] [Related]
16. Regressing malignant melanoma.
Grafton WD
J La State Med Soc; 1994 Dec; 146(12):535-9. PubMed ID: 7844465
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
[TBL] [Abstract][Full Text] [Related]
18. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms.
O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL
J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840
[TBL] [Abstract][Full Text] [Related]
19. Moesin and CD44 expression in cutaneous melanocytic tumours.
Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
[TBL] [Abstract][Full Text] [Related]
20. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
